This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Texaco Inc., Reynaldo Calderon, Other. Active years: 1979-2011.
Company Filing History:
Years Active: 1979-2011
Title: Innovations in Tumor Treatment by Inventor Reynaldo Calderon
Introduction
Reynaldo Calderon, a prominent inventor based in Houston, Texas, has made significant contributions to the field of medical technology with a focus on cancer treatment. With a remarkable portfolio of 14 patents, Calderon's innovative approaches aim to enhance the effectiveness of tumor therapies.
Latest Patents
Among Calderon's most notable inventions are his recent patents which focus on advanced methods for retrograde perfusion of tumor sites. The first patent presents a system and method that enable monitoring and locating a route in vivo, providing a visible image of that route. This innovation facilitates retrograde perfusion of tumors with therapeutic agents, allowing for a closed-loop confirmation of the flow pathway. Consequently, various types and amounts of treating agents can be adjusted and monitored throughout the treatment process.
Another groundbreaking patent is a computerized system designed for monitored retrograde perfusion of tumor sites. This system is capable of collecting, organizing, and storing extensive data during the various phases of treatment. It includes real-time monitoring capabilities that help physicians access past and present treatment data for thorough analysis, enhancing treatment procedures.
Career Highlights
Throughout his career, Reynaldo Calderon has worked with prominent companies such as Texaco Inc., where he garnered valuable experiences that contributed to his inventive endeavors. His innovative mindset has led to advancements in medical treatments that can potentially save lives by improving the delivery and effectiveness of cancer therapies.
Collaborations
Calderon's work frequently involves collaborations with industry colleagues, including notable coworker Billy H. Towell. Together, they have contributed to the development of cutting-edge medical technologies that seek to revolutionize patient care in oncology.
Conclusion
Reynaldo Calderon's inventive spirit and dedication to improving cancer treatment through retrograde perfusion technologies exemplify the impact of innovation in healthcare. His contributions not only advance medical knowledge but also provide valuable tools for physicians working to enhance patient outcomes in the fight against cancer.